Back to top

Analyst Blog

Pfizer Inc. (PFE - Analyst Report) recently extended the expiration date of its tender offer for all outstanding shares of Icagen, Inc. . The tender offer, which was slated to expire on August 31, 2011 (12:00 midnight, New York City time), is now scheduled to expire on September 1, 2011 (12:00 midnight, New York City time).

As of August 31, 2011, about 4,044,035 shares of Icagen’s common stock were validly tendered. Besides this, Pfizer owns 1,067,015 shares of Icagen’s common stock. Taken together, this represents 49% of the fully-diluted shares of Icagen. An additional 107,431 shares need to be validly tendered - this will fulfill the condition for the minimum number of shares that need to be tendered so as to allow Pfizer to accept for payment and pay for such shares.

Pfizer had first announced its intention to acquire Icagen in July 2011 for $6 per share. The total value of the deal, including the value of the shares already owned by Pfizer, is about $56 million.

With the Icagen deal, Pfizer is looking to add to its already diversified product portfolio. Icagen currently has two programs in epilepsy and pain.

Neutral on Pfizer

We currently have a Neutral recommendation on Pfizer, which carries a Zacks #3 Rank (short-term Hold rating). While near-term earnings growth will come in the form of cost cutting and share repurchases, longer-term growth will be dependent on the success of drug development.

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
CENTURY ALU… CENX 27.08 +8.41%
SUPER MICRO… SMCI 26.52 +8.29%
BANCO DO BR… BDORY 16.72 +7.66%
CANADIAN SO… CSIQ 38.15 +7.65%
AROTECH COR… ARTX 3.79 +5.87%